Matthew Cascio, DO

Cancer Specialist (Oncologist), Hematology and Oncology Specialist, Pediatrician (Kids / Children Specialist)

Research at a glance

Focus

The research efforts of Dr. Cascio are supported by STOP Children’s Cancer.

Active clinical trials

This is a 2-arm, randomized, open-label, multicenter, global, Phase 3 trial to evaluate the efficacy, safety, and tolerability of tovorafenib monotherapy versus standard of care (SoC) chemotherapy in participants with pediatric low-grade glioma…

Investigator: Matthew Cascio
Status: Accepting Candidates
Ages: N/A - 25 Years
Sexes: All

My publications

4 publications

2022

CAR T Cell Locomotion in Solid Tumor Microenvironment.

Cells

PubMed • Publisher's site

2021

Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc

PubMed • Publisher's site

2021

Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.

Veterinary immunology and immunopathology

PubMed • Publisher's site

2017

A Case Presentation: Rare Occurrence of an Adolescent Male Presenting With an ATRT and Simultaneous Low-grade Glioneuronal Tumor.

Journal of pediatric hematology/oncology

PubMed • Publisher's site

Research at a glance

Focus

Active clinical trials

My publications

Filter publications

CAR T Cell Locomotion in Solid Tumor Microenvironment.

Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.

A Case Presentation: Rare Occurrence of an Adolescent Male Presenting With an ATRT and Simultaneous Low-grade Glioneuronal Tumor.